Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Case Studies - Flexible outsourcing

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • Outsourcing and the UK pharmaceutical sector

    August 13, 2009
    These quotes are from a report called “The role of the CSO in the UK pharmaceutical sector and key decision criteria for their use”, authored by Beth Rogers, Programme Manager and Principal Lecturer in Sales Management, Portsmouth Business School. The report was based on in-depth interviews with senior decisions-makers in the UK pharmaceutical industry.

  • A total commercializing solution

    August 13, 2009
    ProStrakan opts for an entirely new outsourcing model that delivers benefits above and beyond the standard fee for service model.

  • Exceeding expectations

    August 13, 2009
    Discover how the scale of some marketing challenges stretches even the most powerful companies.

  • Outsourcing risk and responsibility

    August 13, 2009
    Astellas, a company who exchanged risk and responsibility in return for greater market share.

  • Outsourced commercial strategy for multi-market launch

    August 13, 2009
    This study looks at how a UK-based biotech company managed a 12-country launch by outsourcing its requirement for a top performing specialty sales force. Not only did they prove it could be done, but the launch was also achieved in record time and has continued to beat its KPIs.

  • Blockbuster reaches 7 new markets in record time

    August 13, 2009
    This study looks at a fully paid up member of ‘Big Pharma’ and its preparation for the international launch of one of its blockbuster drugs. It examines how outsourcing enabled them to get to market in time and then quickly out-perform the competition.

  • Outsourcing for Pan-European launch success

    August 13, 2009
    This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible.

  • Grown-up thinking to mature product sales

    August 13, 2009
    This study looks at how Roche Italy decided to support the maturing end of their portfolio. And how, by rejecting traditional co-promotion, they found a much more radical, cost effective and successful solution.

  • Launching a Successful Brand in a Genericized Market

    March 27, 2009
    The market for this particular category of muscle relaxants was owned by 10 mg tablets, both branded and generic. Our customer wanted to launch a 5 mg tablet that – contrary to physician and pharmacist preconceptions – was fully as effective as the 10 mg version.

  • How to Keep All Your Licenses in Compliance

    March 25, 2009
    Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses.